NCT03298802View on ClinicalTrials.gov

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

PHASE3RecruitingINTERVENTIONAL
Enrollment

612

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Pre-EclampsiaGestational HypertensionSuperimposed Pre-EclampsiaHypertension, Pregnancy-InducedPostpartum Pregnancy-Induced HypertensionPostpartum Preeclampsia
Interventions
DRUG

Hydrochlorothiazide 50mg Tablet

Hydrochlorothiazide 50 mg per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum.

DRUG

Placebo Tablet

Placebo per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum

Trial Locations (2)

77555

RECRUITING

University of Texas Medical Branch, Galveston

78758

RECRUITING

St. David's North Austin Medical Center, Austin

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER